Who: Ligand Pharmaceuticals/Pfenex Inc. What: Ligand is seeking to acquire Pfenex. Why: The merger will bring Ligand a proprietary protein-expression platform, revenue from ongoing partnerships a
IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Armune BioScience Inc. Armune BioScience Inc. granted AEterna Zentaris Inc. rights to sell its Apifiny prostate cancer diagnostic to desi
SHANGHAI – WuXi AppTec Inc. is not resting on its laurels as the largest contract research organization (CRO) in China, and has announced a plan to build a new integrated biologics development cen
IN VITRO DIAGNOSTICS Alliances Dentamed Ltd. Diamedica Ltd. SIRAM Ltd. Vigilant Biosciences Inc. Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its